KR102210982B1 - 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트 - Google Patents

드로스피레논을 포함하는 약학적 조성물 및 피임용 키트 Download PDF

Info

Publication number
KR102210982B1
KR102210982B1 KR1020197017379A KR20197017379A KR102210982B1 KR 102210982 B1 KR102210982 B1 KR 102210982B1 KR 1020197017379 A KR1020197017379 A KR 1020197017379A KR 20197017379 A KR20197017379 A KR 20197017379A KR 102210982 B1 KR102210982 B1 KR 102210982B1
Authority
KR
South Korea
Prior art keywords
drospirenone
dosage unit
contraceptive
drsp
daily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197017379A
Other languages
English (en)
Korean (ko)
Other versions
KR20190073598A (ko
Inventor
필립프 페린
조세 베라다
도미니크 드루앵
Original Assignee
라보라토리오스 레온 파르마 에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102210982(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 라보라토리오스 레온 파르마 에스에이 filed Critical 라보라토리오스 레온 파르마 에스에이
Priority to KR1020217002806A priority Critical patent/KR102539030B1/ko
Priority claimed from PCT/EP2011/060795 external-priority patent/WO2012000981A1/en
Publication of KR20190073598A publication Critical patent/KR20190073598A/ko
Application granted granted Critical
Publication of KR102210982B1 publication Critical patent/KR102210982B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020197017379A 2010-06-29 2011-06-28 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트 Active KR102210982B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217002806A KR102539030B1 (ko) 2010-06-29 2011-06-28 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10305708.9 2010-06-29
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28
US61/368,396 2010-07-28
PCT/EP2011/060795 WO2012000981A1 (en) 2010-06-29 2011-06-28 Pharmaceutical composition comprising drospirenone and contraceptive kit

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020177019333A Division KR102164693B1 (ko) 2010-06-29 2011-06-28 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217002806A Division KR102539030B1 (ko) 2010-06-29 2011-06-28 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트

Publications (2)

Publication Number Publication Date
KR20190073598A KR20190073598A (ko) 2019-06-26
KR102210982B1 true KR102210982B1 (ko) 2021-02-02

Family

ID=48802149

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197017379A Active KR102210982B1 (ko) 2010-06-29 2011-06-28 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트

Country Status (14)

Country Link
KR (1) KR102210982B1 (enExample)
BR (1) BR122019008317A2 (enExample)
CL (1) CL2012003685A1 (enExample)
CO (1) CO6640328A2 (enExample)
DK (1) DK2588114T3 (enExample)
EC (3) ECSP12012359A (enExample)
ES (1) ES2777886T3 (enExample)
GT (3) GT201200336BA (enExample)
HR (1) HRP20200155T1 (enExample)
HU (1) HUE047689T2 (enExample)
LT (2) LT2588114T (enExample)
MX (3) MX339952B (enExample)
PT (1) PT2588114T (enExample)
ZA (1) ZA201209743B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250129555A (ko) 2024-02-22 2025-08-29 단국대학교 천안캠퍼스 산학협력단 드로스피레논을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250129555A (ko) 2024-02-22 2025-08-29 단국대학교 천안캠퍼스 산학협력단 드로스피레논을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물

Also Published As

Publication number Publication date
LT2588114T (lt) 2020-02-25
MX339952B (es) 2016-06-20
DK2588114T3 (da) 2020-02-17
ECSP15032911A (es) 2016-01-29
GT201200336AA (es) 2017-10-23
ZA201209743B (en) 2014-03-26
GT201200336A (es) 2014-01-14
ECSP15032906A (es) 2016-01-29
HUE047689T2 (hu) 2020-05-28
ECSP12012359A (es) 2013-03-28
BR122019008317A2 (pt) 2020-09-29
KR20190073598A (ko) 2019-06-26
MX2012014629A (es) 2013-05-06
PT2588114T (pt) 2020-02-20
ES2777886T3 (es) 2020-08-06
HRP20200155T1 (hr) 2020-05-01
MX2019004393A (es) 2019-09-09
CO6640328A2 (es) 2013-03-22
CL2012003685A1 (es) 2013-07-05
MX364971B (es) 2019-05-16
LTPA2021523I1 (enExample) 2021-11-10
GT201200336BA (es) 2017-10-23

Similar Documents

Publication Publication Date Title
KR102164693B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
US11439598B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US11413249B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
KR102210982B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
HK40080446A (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
AU2011273605B8 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
HK40026911A (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
HK40026911B (en) Pharmaceutical composition comprising drospirenone for use as a contraceptive
OA16285A (en) Pharmaceutical composition comprising drospirenone and contraceptive kit.

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190617

Application number text: 1020177019333

Filing date: 20170712

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190703

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20191001

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20200629

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20191001

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20200629

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20200131

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20201026

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20200925

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20200629

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20200131

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20210127

Application number text: 1020177019333

Filing date: 20170712

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210127

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210127

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240110

Start annual number: 4

End annual number: 4